147 related articles for article (PubMed ID: 7928805)
1. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
Livermore DM; Seetulsingh P
J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
4. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
5. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.
Thomson KS; Weber DA; Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1990 Apr; 34(4):622-7. PubMed ID: 2344169
[TBL] [Abstract][Full Text] [Related]
7. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
Cherubin CE; Eng RH; Smith SM; Tan EN
J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
9. Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.
Reguera JA; Baquero F; Pérez-Díaz JC; Martínez JL
J Antimicrob Chemother; 1991 May; 27(5):569-75. PubMed ID: 1653204
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
Marre R; Schulz E
Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
[TBL] [Abstract][Full Text] [Related]
11. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
London N; Thomson CJ; Amyes SG; Stobberingh E
FEMS Immunol Med Microbiol; 1995 Apr; 11(2):107-11. PubMed ID: 7640670
[TBL] [Abstract][Full Text] [Related]
12. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
Thomson CJ; Amyes SG
J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta-lactamases from clinical isolates of Escherichia coli.
Henquell C; Chanal C; Sirot D; Labia R; Sirot J
Antimicrob Agents Chemother; 1995 Feb; 39(2):427-30. PubMed ID: 7726509
[TBL] [Abstract][Full Text] [Related]
14. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors.
Brun T; Péduzzi J; Caniça MM; Paul G; Névot P; Barthélémy M; Labia R
FEMS Microbiol Lett; 1994 Jul; 120(1-2):111-7. PubMed ID: 8056282
[TBL] [Abstract][Full Text] [Related]
15. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
[TBL] [Abstract][Full Text] [Related]
16. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
Seetulsingh PS; Hall LM; Livermore DM
J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
[TBL] [Abstract][Full Text] [Related]
17. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
Wu PJ; Shannon K; Phillips I
Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843
[TBL] [Abstract][Full Text] [Related]
18. Frequency of inhibitor-resistant TEM beta-lactamases in Escherichia coli isolates from urinary tract infections in France.
Henquell C; Sirot D; Chanal C; De Champs C; Chatron P; Lafeuille B; Texier P; Sirot J; Cluzel R
J Antimicrob Chemother; 1994 Nov; 34(5):707-14. PubMed ID: 7706166
[TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
Blazquez J; Baquero MR; Canton R; Alos I; Baquero F
Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]